lity adjusted for high-sensitive C-reactive protein as a marker of systemic inflammation is examined as well as the association of EPA with cause-specific death.
& Erythrocyte omega-3 fatty acid proportions were measured at baseline in 3259 participants of the Ludwigshafen Risk and Cardiovascular Health Study (LURIC) using the HS-Omega-3 Index method. Associations of omega-3 fatty acid proportions with mortality were investigated using Cox proportional hazards regression.
Data format Analyzed Experimental factors
Fasting blood samples were obtained by venipuncture at study entry. Fatty acid methyl esters were generated from erythrocytes that had been stored at À 80°C by acid transesterification.
Experimental features
Erythrocyte fatty acid composition was analyzed according to the HSOmega-3 Index technology [2] . Fatty acid methyl esters were analyzed by gas chromatography using a GC2010 gas chromatograph (Shimadzu, Duisburg, Germany) equipped with a 100-m SP2560 column (Supelco, Bellefonte, PA) and using hydrogen as carrier gas. Fatty acids were identified by comparison with a standard mixture of fatty acids characteristic of erythrocytes. Results are presented as a percentage of total identified fatty acids after response factor correction.
Data source location
Ludwigshafen Heart Center in South-West Germany Data accessibility Data is within this article.
Value of the data
Gender-stratified analysis allows the identification of gender-specific effects of omega-3 fatty acids. Examination of nonlinear effects on mortality risk is important to define safe reference values. Investigation of cause-specific mortality might provide hints to possible pathways affected by omega-3 fatty acids.
Data
The data presented in this paper includes Figures and Tables that show the results of gender and subgroup stratified distribution of omega-3 fatty acids proportions in the LURIC study as well as multivariate adjusted analyses of their association with all-cause and cause-specific mortality that extend the results reported in [1] (Figs. 1-7 and Tables 1-6).
Experimental design, materials and methods

Subjects
The LURIC study consists of 3316 Caucasians with an indication for coronary angiography that were between 1997 and 2000 at the Ludwigshafen Heart Center in South-West Germany. A detailed description of the study can be found in Winkelmann et al. [3] . The study was approved by the 'Landesärztekammer' Ethics Committee of the Rheinland-Pfalz state in Germany. Informed written consent was obtained from all participants.
Laboratory procedures
The fatty acid composition of erythrocyte membranes was analyzed using the HS-Omega-3 Index s methodology as described in [1, 2] . Results are given as a percentage of total identified fatty acids after response factor correction. 
Definition of clinical variables and endpoints
The definition of clinical endpoints is detailed in [1, 3] . The 2012 CKD-EPI eGFRcreat-cys equation was used to estimate the glomerular filtration rate [4] . Information on vital status of study participants was requested from local registries. Cardiovascular mortality included sudden cardiac death (n ¼254, 7.8%), fatal myocardial infarction (n¼ 104, 3.2%), death due to congestive heart failure (n ¼148, 4.5%), death after intervention to treat CAD (n¼ 26, 0.8%), fatal stroke (n ¼60, 1.8%), and other causes of death due to CAD (n ¼19, 0.6%).
Statistical analyses
We present the mean and the standard deviation of continuous data when normally distributed and the median and 25th and 75th percentile for variables with a skewed distribution. Categorical data are presented as percentages. ANOVA was used to compare continuous variables between groups (variables with a skewed distribution were log-transformed before entering analysis) and the chisquare test was used for categorical variables. The association of omega-3 fatty acid levels in tertiles 6 . Association of omega-3 fatty acids with all-cause mortality stratified by CAD status. Hazard ratios and 95% CI were calculated for ALA, EPA, DHA and the HS-Omega-3 Index using Cox regression in patients with (A) and without (B) CAD at baseline. Model 1: adjusted for age and gender; model 2: additionally adjusted for BMI, LDL-C, HDL-C, logTG, hypertension, diabetes, smoking, alcohol intake, physical exercise and lipid lowering therapy. ALA: α-linolenic acid; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; TG: triglycerides.
or as Z-transformed values with mortality was assessed by Cox proportional hazard regression with the same adjustments as in [1] . Examination of scaled Schoenfeld residuals provided no evidence for a violation of the proportional hazard assumption. All tests were two-sided and a p value o0.05 was considered statistically significant. SPSS v22.0 (IBM, Ehningen, Germany) and R v3.2.3 (http://www.rproject.org) were used for all analyses. The R-package 'rms' was used for the generation of hazard ratio plots. In a Cox regression model including age, sex, BMI, LDL-C, HDL-C, TG, smoking, alcohol intake, diabetes mellitus, hypertension, physical exercise, lipid lowering therapy and EPA, the EPA proportion was modeled as restricted cubic spline with three knots and plotted against the log hazard. EPA: eicosapentaenoic acid. Table 6 Association between omega-3 fatty acids and cause-specific death. 
